|
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Dimethyl sulfate |
CAS 77-78-1 | ||
(CH3)2SO4 |
RTECS WS8225000 | ||
|
Synonyms & Trade Names Dimethyl ester of sulfuric acid, Dimethylsulfate, Methyl sulfate |
DOT ID & Guide 1595 156 |
||
Exposure
|
NIOSH REL: Ca TWA 0.1 ppm (0.5 mg/m3) [skin] See Appendix A | ||
| OSHA PEL†: TWA 1 ppm (5 mg/m3) [skin] | |||
| IDLH Ca [7 ppm] See: 77781 | Conversion 1 ppm = 5.16 mg/m3 | ||
|
Physical Description Colorless, oily liquid with a faint, onion-like odor. |
|||
|
MW: 126.1 |
BP: 370°F (Decomposes) |
FRZ: -25°F |
Sol(64°F): 3% |
|
VP: 0.1 mmHg |
IP: ? |
|
Sp.Gr: 1.33 |
|
Fl.P: 182°F |
UEL: ? |
LEL: ? |
|
| Class IIIA Combustible Liquid: Fl.P. at or above 140°F and below 200°F. | |||
|
Incompatibilities & Reactivities Strong oxidizers, ammonia solutions [Note: Decomposes in water to sulfuric acid; corrosive to metals.] |
|||
|
Measurement Methods NIOSH 2524 See: NMAM or OSHA Methods |
|
Personal Protection & Sanitation (See protection) Skin: Prevent skin contact Eyes: Prevent eye contact Wash skin: When contaminated Remove: When wet or contaminated Change: No recommendation Provide: Eyewash, Quick drench |
First Aid (See procedures) Eye: Irrigate immediately Skin: Water flush immediately Breathing: Respiratory support Swallow: Medical attention immediately |
|
Important additional information about respirator selection Respirator Recommendations NIOSH At concentrations above the NIOSH REL, or where there is no REL, at any detectable concentration: (APF = 10,000) Any self-contained breathing apparatus that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode (APF = 10,000) Any supplied-air respirator that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode in combination with an auxiliary self-contained positive-pressure breathing apparatus Escape: (APF = 50) Any air-purifying, full-facepiece respirator (gas mask) with a chin-style, front- or back-mounted canister providing protection against the compound of concern/Any appropriate escape-type, self-contained breathing apparatus |
|
| Exposure Routes inhalation, skin absorption, ingestion, skin and/or eye contact | |
| Symptoms Irritation eyes, nose; headache; dizziness; conjunctivitis; photophobia (abnormal visual intolerance to light); periorbital (situated around the eye) edema; dysphonia, aphonia, dysphagia, productive cough; chest pain; dyspnea (breathing difficulty), cyanosis; vomiting, diarrhea; dysuria; analgesia; fever; proteinuria, hematuria (blood in the urine); eye, skin burns; delirium; [potential occupational carcinogen] | |
|
Target Organs
Eyes, skin, respiratory system, liver, kidneys, central nervous system Cancer Site [in animals: nasal & lung cancer] |
|
| See also: INTRODUCTION See ICSC CARD: 0148 See MEDICAL TESTS: 0084 |